Bold Science. African-Led. Impact-Driven
Overview
AIRID, through its involvement in the Pan-African Malaria Vector Research Consortium (PAMVERC), plays a key role in supporting the research and development (R&D) of next-generation insecticide-treated nets (ITNs) developed by Vestergaard Sarl—a global leader in disease prevention technologies.
Project Description
AIRID, through its involvement in the Pan-African Malaria Vector Research Consortium (PAMVERC), plays a key role in supporting the research and development (R&D) of next-generation insecticide-treated nets (ITNs) developed by Vestergaard Sarl—a global leader in disease prevention technologies.
What We Do
As part of this collaboration, AIRID conducts rigorous evaluations of Vestergaard’s ITN products across three major research platforms:
- Laboratory Bioassays: Controlled tests to assess the bioefficacy of Vestergaard’s innovative insecticide formulations against local strains of malaria vectors, including resistant populations.
- Experimental Hut Trials: Semi-field studies in purpose-built huts to measure mosquito mortality, blood-feeding inhibition, and deterrence in realistic exposure scenarios.
- Community-Level Field Studies: Longitudinal evaluations of net durability, bioefficacy, and community acceptance under real-world conditions, in line with WHO guidelines.
Our Impact
By generating high-quality data on the performance and longevity of Vestergaard ITNs, AIRID helps accelerate the development, optimization, and regulatory approval of tools that strengthen malaria control and resistance management strategies across Africa.
Collaborative Science for African Health
This partnership reinforces AIRID’s commitment to science-led innovation, evidence-based public health, and African leadership in global health R&D. Through PAMVERC and other regional networks, AIRID is advancing a shared vision for sustainable malaria control driven by African institutions and local expertise.
